| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Pathfinder's capabilities are now available via the cloud, giving law enforcement new deployment options to accelerate just...
Cellebrite DI Ltd. (NASDAQ:CLBT) ("Cellebrite," the "Company" or "we"), a global leader in premier Digi...
Deutsche Bank analyst Jamie Shelton maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and raises the price target from $15 to...
B of A Securities analyst Tal Liani maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and raises the price target from $13 to...
JP Morgan analyst Brian Essex maintains Cellebrite DI (NASDAQ:CLBT) with a Overweight and raises the price target from $15 t...
Lake Street analyst Frank Takkinen maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and raises the price target from $13.5 t...
Craig-Hallum analyst Jeff Van Rhee maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and raises the price target from $16 to ...
Needham analyst Mike Cikos maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and raises the price target from $14 to $17.
